HomeEQL • STO
add
EQL Pharma AB
Previous close
kr 76.40
Day range
kr 76.20 - kr 78.00
Year range
kr 33.00 - kr 88.00
Market cap
2.24B SEK
Avg Volume
29.72K
P/E ratio
72.07
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 85.25M | 42.99% |
Operating expense | 20.40M | 17.60% |
Net income | 9.56M | 104.32% |
Net profit margin | 11.22 | 42.93% |
Earnings per share | — | — |
EBITDA | 15.87M | 96.75% |
Effective tax rate | 20.63% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.83M | -43.25% |
Total assets | 423.30M | 52.76% |
Total liabilities | 225.40M | 103.86% |
Total equity | 197.89M | — |
Shares outstanding | 29.06M | — |
Price to book | 11.22 | — |
Return on assets | 8.63% | — |
Return on capital | 10.61% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 9.56M | 104.32% |
Cash from operations | 1.42M | 42.22% |
Cash from investing | -10.93M | -122.34% |
Cash from financing | 7.96M | 20,007.50% |
Net change in cash | -1.54M | 61.00% |
Free cash flow | -17.09M | -105.46% |
About
Founded
2006
Website
Employees
20
